羟氯喹联合激素及环磷酰胺治疗狼疮性肾炎40例临床观察(2)
![]() |
第1页 |
参见附件。
[3] 赵小娟,汪国生. 抗疟药在系统性红斑狼疮中的作用进展[J]. 中华临床医师杂志2012,6 (7) :1799-1801.
[4] Petri M,Abuav R,Boumpass D,et al.A clinicians pearls and mythysin rheumatology.Springer,2009:131-160.
[5] KASITANON N,MAGDER L S,PETRI M.Predictors of survival in systemic lupus erythematosus[J].Medicine(Baltimore),2006,85(3):147—156.
[6] 潘思思,刘蕊,刘湘源,等.系统性红斑狼疮患者的用药选择及其与肾脏损害相关性的回顾性分析[J].中华风湿病学杂志,2009,13(10):689—692.
[7] BERTSIAS G,IOANNIDIS J P,BOLETIS J,et a1.EULAR recommendations for the management of systemic lupus erythematosus.Report of a Task Force of the EULAR Standing Committee for International Clinical Studies In eluding Therapeutics[J].Ann Rheum Dis,2008,67(2):195—205.
[8] Ruiz-Irastorza G,Egurbide MV,Olivares N,et al.Vitamin D deficiency in systemic lupus erythematosus: prevalence and clinical consequences. Rheumatology(Oxford),2008,47:920-923.
[9] Hamel P,Abed E,Brissette L,et al.Characterization of oxidized low-density lipoprotein-induced hormesis-like effects in osteoblastic cells.AM J Physiol Cell Physiol,2008,294:C1021-C1033.
您现在查看是摘要介绍页,详见PDF附件。